David Sigmund Liebeskind MD MD, FAAN, FAHA, FANA, FSVIN, FWSO
Neuroimaging, Vascular Neurology
UCLA Stroke Center
Join to View Full Profile
710 Westwood Plaza, C119 RNRCLos Angeles, CA 90095
Phone+1 310-794-6379
Fax+1 310-794-6379
Dr. Liebeskind is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. David Liebeskind is a neurologist in Los Angeles, CA and is affiliated with multiple hospitals in the area, including Ronald Reagan UCLA Medical Center and UCLA Medical Center-Santa Monica. He received his medical degree from NYU School of Medicine and has been in practice 22 years. He also speaks multiple languages, including Spanish. He specializes in neuroimaging and vascular neurology and is experienced in general neurology, stroke, cerebrovascular disease, carotid disease, and neuroimaging.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 1996 - 1999
Beth Israel Deaconess Medical CenterInternship, Internal Medicine, 1995 - 1996
New York University School of MedicineClass of 1995
Certifications & Licensure
CA State Medical License 1997 - 2027
PA State Medical License 1999 - 2004
NY State Medical License 1999 - 2002
American Board of Psychiatry and Neurology Neurology- American Board of Psychiatry and Neurology Vascular Neurology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2021
Clinical Trials
- Vertebrobasilar Flow Evaluation and Risk of Transient Ischemic Attack and Stroke (VERiTAS) Start of enrollment: 2008 Jul 01
- A Study to Evaluate the Effects of the Neuroflo Device in People Who Have Had a Stroke Start of enrollment: 2008 Mar 01
- Safety Study of External Counterpulsation as a Treatment for Acute Ischemic Stroke Start of enrollment: 2009 Dec 01
- Join now to see all
Publications & Presentations
PubMed
- Composite arterial and venous collateral score on single-phase CTA predicts 90-day outcomes in anterior circulation large-vessel occlusion stroke.Hamza Adel Salim, Dhairya A Lakhani, Janet Mei, Manisha Koneru, Aneri Balar
Journal of Neurointerventional Surgery. 2025-09-05 - Changes in Infarct Volume and Cerebral Edema After Mechanical Thrombectomy in Patients With Stroke Randomized to ApTOLL or Placebo: A Secondary Analysis of APRIL Trial.María Hernández-Pérez, Adrián Valls-Carbó, Macarena Hernández-Jiménez, Carlos Molina, José Vivancos Mora
Stroke. 2025-09-01 - Randomized, Proof-of-Concept Trial (RESCUE) of RNS60 as an Adjunct Therapy in Acute Ischemic Stroke.Supurna Ghosh, Jordan S Dubow, Jocelyn Sutherland, Wendy Smith, David Chiu
Stroke. 2025-09-01
Journal Articles
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctElad I. Levy, Qaisar A. Shah, Jawad F. Kirmani, Parita Bhuva, Cathy A. Sila, Michael G. Abraham, Amin Aghaebrahim, Wade S. Smith, Raul G. Nogueira, Brijesh P. Mehta, P..., The New England Journal of Medicine
Other
- Spontaneous cerebral and cervical artery dissection: Treatment and prognosisLiebeskind DS, Saver J
http://www.uptodate.com/contents/spontaneous-cerebral-and-cervical-artery-dissection-treatment-and-p
UpToDate, Wolters Kluwer Health - 2012-09-19 - Spontaneous cerebral and cervical artery dissection: Clinical features and diagnosisLiebeskind DS, Saver J
http://www.uptodate.com/contents/spontaneous-cerebral-and-cervical-artery-dissection-clinical-featur
UpToDate, Wolters Kluwer Health - 2013-01-02
Authored Content
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
- Thrombectomy 6 to 24 Hours After Stroke with a Mismatch Between Deficit and InfarctNovember 2017
Press Mentions
Middle Meningeal Artery Embolization in the Treatment of Chronic HeadachesJune 20th, 2025- Stroke Patients Discharged from Hospital Sooner When Administered Revalesio's RNS60; New Statistically Significant Finding from Revalesio's Phase 2 Clinical TrialApril 9th, 2025
- GNT Pharma Reports Significant Improvements in Stroke Patients Treated with Its Pioneering Phase 3 Drug Nelonemdaz™December 11th, 2024
- Join now to see all
Grant Support
- CAPTIVA-MRIYALE UNIVERSITY2023–2030
- Shear Stress and Endothelial Pathophysiology in Intracranial AtherosclerosisUNIVERSITY OF CALIFORNIA LOS ANGELES2020–2030
- Platelet Expression of FcgammaRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial AtherosclerosisUNIVERSITY OF CALIFORNIA LOS ANGELES2022–2027
- Carotid Revascularization and Medical Management for Asymptomatic CarotidStenosis Trial - Hemodynamics (CREST-H)COLUMBIA UNIVERSITY HEALTH SCIENCES2017–2027
- CAPTIVA-MRIYALE UNIVERSITY2023–2024
- Modeling Of Collateral Perfusion In The Ischemic BrainNational Institute Of Neurological Disorders And Stroke2011
- Therapeutic Aqueous Oxygen In Stroke (TAO)National Institute Of Neurological Disorders And Stroke2008–2011
- Neuroimaging CoreNational Institute Of Neurological Disorders And Stroke2008–2011
- Collateral Circulation In Acute Ischemic StrokeNational Institute Of Neurological Disorders And Stroke2006–2010
Professional Memberships
- Society of Vascular and Interventional Neurology (SVIN)President
- American Society of Neuroimaging (ASN)Past-President
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
